Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study (vol 26, pg 314, 2018)

Rajae Touzani , Dede Sika Kossi , Zou Zhaomin , Nathanael Charrier , Sandrine Baffert , Emmanuel Barillot , Stephane Bezieau , Isabelle Borget , Lucie Coppin , Clothilde Descapentries , Isabelle Durand-Zaleski , Sebastien Forget , Thierry Frebourd , Philippe Guardiola , Nicolas Goardon , Claude Houdayer , Philippe Hupe , Ludovic Lacroix , Julie Leclerc , Alexandra Lespagnol , Stephanie Longuemare , Patricia Marino (1) , Jean Mosser , Marie-Francoise Odou , Lionel Perrier , Claude Preudhomme , Francoise Revillion , Etienne Rouleau , Nicolas Sevenet , Isabelle Soubeyran , Dominique Vaur , Ngseco Grp

1 SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale

Domaines: Sciences du Vivant [q-bio]

Rajae Touzani, Dede Sika Kossi, Zou Zhaomin, Nathanael Charrier, Sandrine Baffert, et al.. Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study (vol 26, pg 314, 2018). European Journal of Human Genetics, 2018, 26 (9), pp.1396-1397. ⟨10.1038/s41431-018-0194-3⟩. ⟨hal-02146886⟩